Birkbeck, University of London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
The Hong Kong Polytechnic University Featured PhD Programmes
"tau"×
10 miles

tau PhD Projects, Programs & Scholarships

We have 11 tau PhD Projects, Programs & Scholarships

  • "tau" ×
  • clear all
Order by 
Showing 1 to 10 of 11
  Investigating the impact of chaperone activation on tauopathy in Alzheimer’s Disease
  Dr HJ Chen, Dr M Plevin
Application Deadline: 5 January 2020

Funding Type

PhD Type

Dementia is an age-linked progressive disorder that affects around 850,000 people in the UK. Causing a substantial economic and social impact, it presents one of the toughest medical challenges with no effective therapy available for the disease.
  Screening of chemical libraries using iPS models for investigating the role of prion protein in Alzheimer’s disease
  Prof B Chen
Applications accepted all year round

Funding Type

PhD Type

Background. AD has been identified as a protein misfolding disease (proteopathy). The disease is caused by accumulation of two major amyloids.
  Investigating how activated monocytes/macrophages infiltrate into the brain to stimulate neuroimmune responses
  Dr R Chang
Applications accepted all year round

Funding Type

PhD Type

The Laboratory of Neurodegenerative Disease (Dr. Raymond CC Chang’s Lab. Facebook. https://www.facebook.com/Neurodeglab) is looking for a pro-active PhD student with first class honor or equivalent.
  Progression in Neurodegenerative Tauopathies: Neuroimaging Biomarkers and Disease Models
  Dr J Rowe, Dr T Rittman
Application Deadline: 3 December 2019

Funding Type

PhD Type

One of the challenges in understanding neurodegenerative disorders is to relate the effect of genetic and molecular changes associated with disease to the level of the whole brain.
  Investigations into the neuroprotective actions of leptin and leptin-based mimetics in models of tauopathy.
  Dr J Harvey
Applications accepted all year round

Funding Type

PhD Type

In neurodegenerative disorders like Alzheimer’s disease (AD), synaptic communication within brain networks are impaired leading to significant memory deficits and dementia.
  The neural circuit basis of spatial memory loss in Alzheimer’s disease. PhD in Medical Studies (MRC GW4 BioMed DTP)
  Dr J Witton
Application Deadline: 25 November 2019

Funding Type

PhD Type

Supervisory team. Dr Jonathan Witton, College of Medicine and Health, University of Exeter. Dr Michael Ashby, Faculty of Life Sciences, University of Bristol.
  Understanding how altered GABA signalling in the brain’s master clock contributes to circadian rhythm disruption in Alzheimer’s disease. PhD in Medical Studies (MRC GW4 BioMed DTP)
  Dr M Belle
Application Deadline: 25 November 2019

Funding Type

PhD Type

Supervisory team. Dr Mino Belle, Institute of Biomedical and Clinical Science, Medical School, University of Exeter. Dr James Hodge, Faculty of Life Sciences, University of Bristol.
  ATLAS: Searching for Di-Higgs Boson Production
  Research Group: Particle Physics and Particle Astrophysics
  Dr T Vickey
Applications accepted all year round

Funding Type

PhD Type

It’s possible that the 125 GeV Higgs boson discovered by the ATLAS and CMS Experiments is only one of several neutrally-charged Higgs bosons predicted by theories beyond the Standard Model of particle physics.
  Mechanisms of selective cell vulnerability to protein assembly propagation in neurodegenerative disease
  Dr B Falcon
Application Deadline: 3 December 2019

Funding Type

PhD Type

The assembly of a small number of proteins into amyloid structures within neurons and, in some cases, glia underlies neurodegenerative disease.
  Fly, mouse and computational modelling of the effect of Alzheimer’s disease on clock neuron excitabilit
  Dr J Hodge, Prof K Tsaneva-Atanasova
Application Deadline: 25 November 2019

Funding Type

PhD Type

Alzheimer’s disease (AD) involves amyloid-B and tau accumulation resulting in memory, sleep and circadian rhythm loss. How this occurs is unknown hampering the development of effective AD drugs.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.